CAR T-Cell Therapy · SinoUnited Health
Check eligibility

CAR T-cell therapies at SinoUnited Health.

Seven CAR T-cell therapies approved by China's National Medical Products Administration (NMPA) — six of them developed in China — for relapsed and refractory blood cancers. Each is directed at a specific target and treats specific conditions.

See the therapies
A CAR T-cell therapy patient giving a thumbs-up from his bed alongside his SinoUnited Health care team in Shanghai.

A CAR T-cell therapy is directed at a target on the surface of the cancer cell. The therapies below are grouped by that target — CD19 for B-cell lymphomas and leukemias, BCMA for multiple myeloma. Each therapy page lists the conditions it treats, who may be eligible, and what to expect. Which therapy is right is decided by the medical team after assessment — it isn't something you choose yourself.

Each therapy leads with its short name, with the full generic name alongside — the form used in the medical literature and on each therapy page.

A patient and two clinicians at SinoUnited Health reviewing records beside CAR T-cell therapy equipment in a treatment room overlooking Shanghai.

CD19 for B-cell lymphomas & leukemias

Five CAR T-cell therapies directed at the CD19 target.

BCMA for multiple myeloma

Two CAR T-cell therapies directed at the BCMA target.

Solid tumor program

A different program from the blood-cancer therapies above — its own target, its own indication, and its own page.

Not sure which therapy applies?

Most patients start from their diagnosis.

A patient rarely knows which therapy they need — they know their disease. Browse by condition to see which CAR T-cell therapies are approved to treat it, then follow the links back to each therapy.

Explore conditions →
How the right therapy is chosen

Which therapy is right — and whether CAR T-cell therapy is an option at all — is determined by SinoUnited Health's medical team after reviewing your records. A remote assessment is free, and you'll hear back within 24 hours.

The first step

Find out which CAR T-cell therapy may be an option for you.

Start a free remote assessment by SinoUnited Health's international care team — a response within 24 hours.